About this Book

In recent years, cancer drug development has witnessed significant advancements driven by breakthroughs in understanding the molecular and genetic basis of cancer. These advancements have led to the emergence of targeted therapies, immunotherapies, and precision medicine approaches. However, challenges such as drug resistance and tumor heterogeneity persist, necessitating ongoing research and collaboration for improved cancer treatments.

With cancer being a complex and heterogeneous disease, the need for innovative therapeutic approaches is ever more crucial. This collection celebrates the success stories achieved in drug discovery for cancer treatment while providing insights into the open challenges that researchers continue to face.